Skip to content

    Eton Pharmaceuticals (ETON) stock price & financials

    View ETON earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+245.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $10.32M
    $11.65M
    $17.28M
    $18.93M
    $22.46M
    +117.5%
    $21.28M
    +82.7%
    $24.27M
    +40.4%
    $37.59M
    +98.6%
    Strengthening
    Operating Profit
    $509.0K
    $629.0K
    -$470.0K
    -$1.48M
    -$1.36M
    -367.8%
    $2.46M
    +291.7%
    $2.41M
    $12.79M
    Strengthening
    Net Profit
    $627.0K
    -$598.0K
    -$1.57M
    -$2.58M
    -$1.93M
    -407.3%
    $1.48M
    $1.55M
    $11.58M
    Strengthening
    EPS
    $0.02
    $-0.06
    $-0.10
    $-0.07
    -450.0%
    $0.06
    $0.42
    Strengthening
    Other Income
    -$8.0K
    -$1.14M
    Interest
    $211.0K
    $1.16M
    $1.21M
    +474.4%
    $1.14M
    -2.3%
    Stable
    Depreciation
    Profit before Tax
    $501.0K
    -$511.0K
    -$1.50M
    -$2.52M
    -$1.96M
    -490.2%
    $1.41M
    $1.57M
    $11.72M
    Strengthening
    MarginsOPM
    4.9%
    5.4%
    -2.7%
    -7.8%
    -6.1%
    -223.1%
    11.6%
    +114.4%
    9.9%
    34.0%
    Strengthening
    Tax
    -25.1%
    -17.0%
    -4.9%
    -2.6%
    1.4%
    -4.9%
    +71.3%
    1.3%
    1.2%
    Strengthening
    ReturnsROIC
    -0.6%
    0.6%
    1.6%
    2.6%
    1.9%
    -1.5%
    -348.0%
    -1.6%
    -198.9%
    -11.7%
    -547.9%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$26.73M$12.07M$21.30M$14.41M$16.30M$21.39M$14.94M$25.94M$26.84M
    Short-Term Investments
    Total Current Assets$27.50M$15.01M$24.70M$23.60M$20.00M$26.84M$41.02M$60.58M$68.60M
    Net PP&E$773.0K$1.28M$1.00M$219.0K$260.0K$150.0K$209.0K$636.0K$1.47M
    Goodwill
    Intangibles$725.0K$575.0K$3.62M$4.75M$4.74M$34.88M$30.88M$45.68M
    Total Assets$28.33M$17.07M$26.32M$27.46M$25.03M$31.74M$76.12M$92.11M$115.81M
    LiabilitiesTotal Current Liabilities$2.02M$1.96M$3.79M$4.56M$6.46M$16.24M$19.95M$38.49M$45.12M
    Short-Term Debt$1.42M$1.03M$5.38M$0$8.79M$8.82M
    Long-Term Debt$4.54M$6.53M$5.26M$5.38M$0$29.81M$21.77M$19.08M
    Long-Term Leases$19.0K$99.0K$15.0K$107.0K$22.0K$107.0K$460.0K$1.08M
    Total Liabilities$2.02M$6.52M$10.66M$9.84M$11.95M$16.26M$51.70M$65.96M$69.22M
    EquityCommon Stock & APIC$18.0K$18.0K$24.0K$25.0K$25.0K$26.0K$27.0K$27.0K$28.0K
    Retained Earnings-$45.87M-$64.19M-$92.16M-$94.11M-$103.13M-$104.07M-$107.89M-$112.49M-$99.36M
    Total Equity$26.30M$10.55M$17.63M$17.63M$13.08M$15.48M$24.43M$26.15M$46.59M
    HighlightsNet Cash / (Debt)$7.73M$9.89M$16.01M-$14.88M-$4.62M-$1.06M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$8.14M-$18.03M-$22.35M-$4.72M$4.82M$6.82M$969.0K$10.52M$15.13M
    Cash from Investing-$236.0K-$1.85M-$50.0K-$2.56M-$2.79M-$775.0K-$40.01M-$333.0K-$15.40M
    Cash from Financing$21.96M$5.20M$31.63M$391.0K-$134.0K-$957.0K$32.59M$815.0K$1.73M
    SummaryCapital Expenditure-$236.0K-$1.10M-$50.0K-$9.0K-$38.0K$0-$26.0K-$333.0K-$403.0K
    Free Cash Flow-$8.38M-$19.12M-$22.40M-$4.73M$4.78M$6.82M$943.0K$10.19M$14.73M
    FCF Margin-1994.0%-57425.6%-21.7%22.5%21.5%2.4%12.7%14.0%

    Ratios